LAUNCH OF PAIN TREATMENT LYRICA® OD TABLET FORMULATION IN JAPAN | News Release：2017

For Print
June 8, 2017

Pfizer Japan Inc.
Eisai Co., Ltd.

Pfizer Japan Inc. (Headquarters: Tokyo, President and Representative Director: Ichiro Umeda, “Pfizer”) and Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) have announced that Lyrica® OD Tablets 25mg, 75mg, 150mg (OD tablet: orally disintegrating tablet), a new formulation following pain treatment Lyrica Capsules (pregabalin), will be launched on June 8.

Lyrica Capsules are co-promoted in Japan by Pfizer and Eisai, with both companies working to provide information on its proper use. Likewise, Lyrica OD Tablets will also be co-promoted by both companies in Japan.

Lyrica is indicated for use in patients with neuropathic pain and pain associated with fibromyalgia. Many of these patients are elderly, and there are cases of patients having difficulty swallowing. Lyrica OD Tablets dissolve swiftly inside the mouth, making it an easy form for these patients to take, and are expected to lead to increased convenience when taking medicine.

Through Lyrica, Pfizer and Eisai will continue to contribute to improvement of quality of life in patients suffering from neuropathic pain and pain associated with fibromyalgia.

Media Inquiries:

Pfizer Japan Inc. Corporate Communications

+81-3-5309-6644

Eisai Co., Ltd. Public Relations Department

+81-3-3817-5120

Pain Treatment Lyrica OD Tablets Outline

*You can scroll to the left or right here

Product Name:	Lyrica® OD Tablet 25mg•75mg•150mg
Generic Name:	Pregabalin
Approval Date:	February 17, 2017
NHI Price Listing Date	May 31, 2017
Launch Date	June 8, 2017
Manufactured and Marketed by:	Pfizer Japan Inc.
Co-promoted by:	Eisai Co., Ltd.
Indications and Usage	Neuropathic pain, Pain associated with fibromyalgia
Dosage and Administration	Neuropathic pain The usual adult dosage for oral use begins at 150 mg/day of pregabalin twice daily, and should be gradually increased to 300 mg/day over 1 week or more. Dosage should be adjusted, depending on age and symptoms. However, the maximum daily dose should not be beyond 600 mg and should be orally administered twice daily. Pain associated with fibromyalgia The usual adult dosage for oral use begins at 150 mg/day of pregabalin twice daily, and should be gradually increased to 300 mg/day over 1 week or more and then maintained at 300-450 mg/day as need. Dosage should be adjusted, depending on age and symptoms. However, the maximum daily dose should not be beyond 450 mg and should be orally administered twice daily.
Price	Lyrica OD Tablet 25mg: 67.80 yen Lyrica OD Tablet 75mg: 112.90 yen Lyrica OD Tablet 150mg: 155.00 yen
Packaging	Lyrica OD Tablet 25mg: 100 tablets (PTP), 500 tablets (PTP) Lyrica OD Tablet 75mg: 100 tablets (PTP), 500 tablets (PTP) Lyrica OD Tablet 150mg: 100 tablets (PTP)

Full text